List of the best stocks to buy now:Last week, our experts named nine "best of the best" stocks for Money Morning readers.
best stocks to buy now
Best stocks to buy roundup:Last week, we highlighted the "best of the best" stocks for Money Morning readers to boost their portfolios ahead of the New Year.
Choosing the best stock to buy to play the commercial space race has enormous upside potential for investors.
That's because the private space industry is worth billions. Exemplar is news today (Tuesday) that NASA awarded Boeing (NYSE: BA) and SpaceX - which is backed by Tesla (Nasdaq: TSLA) CEO Elon Musk - a whopping $6.8 billion contract for its Commercial Crew program.
Best stocks to buy for the week ending Sept. 12, 2014:Last week for Money Morning Members, we highlighted ten stocks - five of which are some of the best dividend stocks to own in 2015.
Four of our dividend plays hedge against the Fed's upcoming interest rate hike. Plus we have an auto sector pick from China, three biotech penny stocks, and more in our newest list of the best stocks to buy now...
Best stocks to buy for the week ending Sept. 5, 2014:Last week for Money Morning Members, we highlighted seven stocks - five of which hail from the profit-rich tech sector.
Best stocks to buy for the week ending Aug. 29, 2014:Last week for Money Morning Members, we highlighted seven stocks that bring readers the "best of the best" in four sectors currently overflowing with upside potential.
One pick hails from the 3D printing market that's expected to quadruple within the next four years. Another is in the fleet and fuel management sector - it's rapidly growing at a compound annual growth rate of 22.8%. We've got three energy stocks to buy from the most productive natural gas region in the U.S. And we highlighted two silver ETFs that play some promising numbers that were just reported from August.
Best stocks to buy for the week ending Aug. 22, 2014:Last week for Money Morning Members we highlighted 11 top stock picks across the globe.
One value buy is a Calif.-based biotech firm that works in cancer treatment technology using genome sequencing - currently a $20 billion market. Another is a more than 100-year-old German company that's about to unlock its stock's value in a spin-off.
Last week for Money Morning Members we highlighted five of the most promising stock picks across three of today's fastest-moving sectors.
Two are plays on booming Chinese e-commerce growth, two are picks in the semiconductor industry (which just notched global sales of $26.86 billion in May), and one taps into the more than $13 billion-per-year real estate advertising industry.
Gold has outperformed other asset classes so far in 2014. And with geopolitical tensions raging in Eastern Europe and in the Middle East, inflation on the rise, and Asian demand soaring through the roof, the yellow metal's run won't be over anytime soon.
But it's not the only way to invest today...
Last week the Dow slumped more than 300 points in one day - but Money Morning Members weren't worried; they were prepared.
We featured an array of stocks that will thrive even in a market sell-off – including a tech giant with a groundbreaking new technology, two stocks that are ripe for merger activity, and a winner in the Twitter vs. Facebook stock debate.
Last week we gave Money Morning Members a fresh batch of the best stocks to buy now.
We shared two bioscience picks that are set to soar on positive diabetes drug trial results, four tech stocks and three tech exchange-traded funds, and a once-great software giant that will rebound on four specific catalysts.
Each week our experts dish out the latest profit plays for our Money Morning Members - all for free.
Last week our picks included two ways to cash in on sub-Saharan Africa's $1 trillion resource rush, a leader-turned-laggard that's about to reverse course and bring tremendous upside to investors, and a way to profit from the end of the U.S. oil export ban.
Usually the best stocks to buy have not already tripled in value within the past six months.
But then there's Intercept Pharmaceuticals Inc. (Nasdaq: ICPT).
This biotech stock soared more than 500% in two days on the news its innovative and promising hepatitis drug obeticholic acid, or OCA, had a trial stopped early because the drug met the goals of the study.
Bulls have refused to be distracted by some negative news that has pushed the stock back under $300 in the meantime.
Each week our Money Morning experts dish out the latest profit plays – and asset-protection moves – for our Money Morning Members – all for free.
Last week, Money Morning’s best stocks to buy included a George Soros-inspired play that’s already doubled once. We also covered three tech investing strategies that promise tremendous upside and a new ETF that could be the perfect fit for a goldbug’s portfolio.
We scoured penny stocks for some of the most promising investments they have to offer, and came up with 6 penny stocks in two top sectors – healthcare and energy. We highlighted a dozen stocks on the elite “Dividend Aristocrats” list, and even weighed in on a Bitcoin retirement play.
Last week, Money Morning's best stocks to buy centered around tech stocks, including a "backdoor" play on the AT&T/DirecTV merger, a swooping defense tech stock that taps into the entire U.S. defense sector, and a leading semi-conductor stock that's ripe to buy right now.
We also scoured dividend stocks and penny stocks for some of the most promising investments those fields have to offer. And we showed readers how they can get ahead of the investment curve and avoid the pitfalls most investors don't, with just a few easy steps.